Vraylar (Cariprazine) Withdrawal Symptoms: What To Expect After Discontinuation
Vraylar (Cariprazine) is an atypical antipsychotic that is most frequently prescribed as a pharmacological intervention for schizophrenia and bipolar disorder. The medication functions predominantly as a: D3 and D2 receptor partial agonist, 5-HT2B receptor antagonist, and 5-HT1A partial agonist. To a less significant extent, Vraylar interacts with H1 receptors and 5-HT2A receptors as an antagonist. …